| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/0003319706297741 © 2007 SAGE Publications Efficacy and Tolerability of Liposomal Heparin Spraygel as an Add-on Treatment in the Management of Superficial Venous ThrombosisDepartment of Angiology, Hanuschkrankenhaus, Vienna, Austria, Reinhold.katzenschlager{at}wgkk.sozvers.at
Department of Vascular Surgery, LKH, Salzburg, Austria
Department of Angiology, BAZ Country Hospital, Miskolc, Hungary
Department of Cardiovascular Surgery, Szabolcs, Budapest, Hungary
Institute of Surgery, Military Medical Institute, Warszawa, Poland
Department of Angiology, Hanuschkrankenhaus, Vienna, Austria
Ambulance of Vascular Surgery, Kapiszoryho, Nove Zamky, Slovakia
Clin. General Surgery, Medical School, Warzawa, Poland
Ars-Medica, Private Clinic, Wroclaw, Poland
Department of Vascular Surgery, Hosp. St. Grandego, Krakow, Poland Superficial venous thrombosis usually resolves spontaneously in a few weeks. In most cases, treatment includes peroral analgesics or nonsteroidal anti-inflammatory drugs accompanied by the recommendation to wear elastic stockings and perform regular mild ambulation. In contrast to this "standard treatment," a recent ACCP guideline has recommended that patients affected by spontaneous superficial thrombophlebitis be treated with intermediate doses of unfractionated or low-molecular-weight heparin. This study was designed to assess the efficacy of topically applied heparin spraygel in terms of reduction of local symptoms and signs of superficial venous thrombosis.
|